Current and historical daily PE Ratio for Aker BioMarine ASA (
OSL:AKBM
) from 2020 to May 27 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Aker BioMarine ASA stock (OSL:AKBM) PE ratio as of May 27 2024 is 139.27.
More Details
Aker BioMarine ASA (OSL:AKBM) PE Ratio (TTM) Chart
Aker BioMarine ASA (OSL:AKBM) PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Total 985
- 1
- 2
- 3
- 4
- 5
- 6
- 11
| Aker BioMarine ASA PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-28 | 139.3 | 2024-03-15 | At Loss |
| 2024-05-27 | 139.3 | 2024-03-14 | At Loss |
| 2024-05-24 | 140.4 | 2024-03-13 | At Loss |
| 2024-05-23 | 141.2 | 2024-03-12 | At Loss |
| 2024-05-22 | 142.2 | 2024-03-11 | At Loss |
| 2024-05-21 | 142.0 | 2024-03-08 | At Loss |
| 2024-05-16 | 137.9 | 2024-03-07 | At Loss |
| 2024-05-15 | 141.2 | 2024-03-06 | At Loss |
| 2024-05-14 | 142.8 | 2024-03-05 | At Loss |
| 2024-05-13 | 144.7 | 2024-03-04 | At Loss |
| 2024-05-10 | 145.1 | 2024-03-01 | At Loss |
| 2024-05-08 | 141.2 | 2024-02-29 | At Loss |
| 2024-05-07 | 139.3 | 2024-02-28 | At Loss |
| 2024-05-06 | 141.0 | 2024-02-27 | At Loss |
| 2024-05-03 | 136.4 | 2024-02-26 | At Loss |
| 2024-05-02 | 133.5 | 2024-02-23 | At Loss |
| 2024-04-30 | 135.8 | 2024-02-22 | At Loss |
| 2024-04-29 | 135.6 | 2024-02-21 | At Loss |
| 2024-04-26 | 137.9 | 2024-02-20 | At Loss |
| 2024-04-25 | 140.4 | 2024-02-19 | At Loss |
| 2024-04-24 | 139.3 | 2024-02-16 | At Loss |
| 2024-04-23 | 142.2 | 2024-02-15 | At Loss |
| 2024-04-22 | 136.0 | 2024-02-14 | At Loss |
| 2024-04-19 | 137.1 | 2024-02-13 | At Loss |
| 2024-04-18 | 133.5 | 2024-02-12 | At Loss |
| 2024-04-17 | 130.0 | 2024-02-09 | At Loss |
| 2024-04-16 | 125.9 | 2024-02-08 | At Loss |
| 2024-04-15 | 127.1 | 2024-02-07 | At Loss |
| 2024-04-12 | 132.5 | 2024-02-06 | At Loss |
| 2024-04-11 | 126.5 | 2024-02-05 | At Loss |
| 2024-04-10 | 127.5 | 2024-02-02 | At Loss |
| 2024-04-09 | 130.4 | 2024-02-01 | At Loss |
| 2024-04-08 | 129.6 | 2024-01-31 | At Loss |
| 2024-04-05 | 125.7 | 2024-01-30 | At Loss |
| 2024-04-04 | 124.2 | 2024-01-29 | At Loss |
| 2024-04-03 | 123.8 | 2024-01-26 | At Loss |
| 2024-04-02 | 124.6 | 2024-01-25 | At Loss |
| 2024-03-27 | At Loss | 2024-01-24 | At Loss |
| 2024-03-26 | At Loss | 2024-01-23 | At Loss |
| 2024-03-25 | At Loss | 2024-01-22 | At Loss |
| 2024-03-22 | At Loss | 2024-01-19 | At Loss |
| 2024-03-21 | At Loss | 2024-01-18 | At Loss |
| 2024-03-20 | At Loss | 2024-01-17 | At Loss |
| 2024-03-19 | At Loss | 2024-01-16 | At Loss |
| 2024-03-18 | At Loss | 2024-01-15 | At Loss |
Aker BioMarine ASA (OSL:AKBM) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Aker BioMarine ASA
ISIN : NO0010886625
Share Class Description:
OSL:AKBM: Ordinary SharesCompare
Compare
Traded in other countries / regions
AKBM.Norway1PG.GermanyAKBMo.Sweden IPO Date
2020-07-06Description
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include 1) The Ingredients segment involves offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products. 2) The Brands segment focuses on human consumer goods, with Lang Pharma Nutrition (Lang) and Epion as its two main components. Lang produces and distributes private-label vitamins and supplements to retailers in the U.S. market and Epion is Aker BioMarine's consumer brand company.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers